22 results on '"Nador, Guido"'
Search Results
2. A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myeloma
3. A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma
4. A Matching-Adjusted Indirect Comparison of the Efficacy of Elranatamab Versus Physician's Choice of Treatment in Patients with Triple-Class Exposed/Refractory Multiple Myeloma
5. P-249 The association between age, performance status, frailty and outcomes in real-world clinical practice among patients with triple-class exposed multiple myeloma
6. P-248 Real-world outcomes of triple-class exposed multiple myeloma patients by treatment experience: the assocaition of prior lines and penta-refractoriness with progression-free and overall survival
7. P-250 The relationship of extramedullary disease and high-risk cytogenetics on real-world outcomes among patients with triple-class exposed multiple myeloma
8. Prospective Assessment of Tumour Burden and Bone Disease in Plasma Cell Dyscrasias Using DW-MRI and Exploratory Bone Biomarkers
9. P-043: Prospective assessment of myeloma tumour burden and bone disease using DW-MRI and exploratory bone biomarkers
10. Multiple myeloma increases nerve growth factor and other pain-related markers through interactions with the bone microenvironment
11. Unplanned admissions for patients with myeloma in the UK: Low frequency but high costs
12. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures
13. Elective Vs Non-Elective Hospital Admissions By Patients with Multiple Myeloma in England 2014 - 2018
14. Corrigendum to ‘Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”’ [Leuk Res 37 (2013) 1233–1240]
15. A Phase II Multi-Center Trial Of Pentostatin Plus Cyclophosphamide With Ofatumumab (PCO) In Older Previously Untreated Chronic Lymphocytic Leukemia (CLL) Patients
16. Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: The experience of the “Rete Ematologica Lombarda”
17. A Case of Massive Intracerebral Haemorrage in Advanced Myelofibrosis Due to Atypical Metaplasia.
18. Prognostic value of circulating CD34+ cells in myelodysplastic syndromes
19. Outcome of hyperleukocytic adult acute myeloid leukaemia: A single-center retrospective study and review of literature
20. Prospective monocentric study of non-tunnelled central venous catheter-related complications in hematological patients
21. Prognostic Significance of CD33, CD34 and CD117 Expression on Bone Marrow Blasts of Patients with Myelodysplastic Syndromes.
22. Complications of Central Venous Catheters in Patients with Hematologic Malignancy: Analysis of Risk Factors.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.